ArticleCancer drug resistance (Alhambra, Calif.)2022

Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq.

Oscar Zuniga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.